FDA approves Watson’s generic version of Alzheimer’s treatment
CORONA, Calif. The Food and Drug Administration has approved Watson Pharmaceuticals’ generic version of Razadyne ER capsules, Watson announced on Tuesday, Dec. 16.
The extended-release capsules, known generically as galantamine hydrobromide, are used for treating Alzheimer’s disease. Watson will market them in 8 mg, 16 mg and 24 mg strengths.
The branded version of the drug, made by Johnson & Johnson, had sales of $112 million for the 12 months ending in September, according to IMS Health data.
Gilead sues Teva over approval application for generic Truvada
NEW YORK Gilead Sciences has filed a lawsuit against Israeli generic drug maker Teva Pharmaceutical Industries and a subsidiary.
Gilead, which filed the suit Friday in a United States District Court in New York, alleged that Teva committed patent infringement when it filed an approval application with the Food and Drug Administration for a generic version of Truvada (emtricitabine), a drug for treating HIV.
Gilead has a license to manufacture and sell the drug from Emory University in Atlanta.
Take Care adds another clinic to its network in Miami/Fort Lauderdale area
CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has opened one new clinic in the Miami/South Fort Lauderdale area. The opening marks the 10th Take Care Clinic in the market.
The company currently operates 313 clinics in 18 states.